Page last updated: 2024-08-24

topotecan and Thoracic Neoplasms

topotecan has been researched along with Thoracic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; RavĂ , L1
Berlin, J; Boothman, D; Forouzannia, A; Hutson, P; Mehta, M; Schiller, J; Storer, B; Wilding, G1

Trials

1 trial(s) available for topotecan and Thoracic Neoplasms

ArticleYear
A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.
    Lung cancer (Amsterdam, Netherlands), 2004, Volume: 44, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Diarrhea; Esophagitis; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Radiation-Sensitizing Agents; Thoracic Neoplasms; Thrombocytopenia; Topotecan; Treatment Outcome

2004

Other Studies

1 other study(ies) available for topotecan and Thoracic Neoplasms

ArticleYear
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:4

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Mesna; Neuroblastoma; Pilot Projects; Risk Factors; Thoracic Neoplasms; Topotecan; Treatment Outcome

2011